Generic Pharmaceutical Manufacturing in the US - Industry Market Research Report

Generic Pharmaceutical Manufacturing in the US

The Generic Pharmaceutical Manufacturing industry is expanding at a steady pace, with revenue expected to increase over the five years to 2019. Increasing access to health insurance, rising total health expenditure and efforts to control prescription medication costs benefited generic manufacturers. The increasing use of generic and biosimilar products has already resulted in trillions of dollars in savings for employers, health plans, patients and the government. Increasing price scrutiny of branded prescriptions has enabled generic manufacturers to take advantage of pricing pressures and improve patient access to medicine. Over the five years to 2024, generic manufacturers are expected to lobby for policies that encourage cost savings and access to affordable medicines. Furthermore, as a growing number of patents are set to expire over the coming years, generic manufacturers are expected to have robust product pipelines. During the outlook period, generic operators are expected to explore new product lines, including biosimilars, and expand into new and emerging markets where consumers can only afford generics.

Generic pharmaceutical and medicine manufacturers develop prescription and over-the-counter drug products that are used to prevent or treat illnesses in humans or animals. Generic drugs are produced and distributed without patent protection, and industry operators are not significantly engaged in the research and development of new drugs. The industry does not include manufacturers of nutritional supplements or cosmetic beauty products.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry key players and their market shares.


  • About this Industry
  • Industry at a Glance
    • Table Key Statistics Snapshot
    • Table Revenue vs. employment growth
    • Table Products and services segmentation (2019)
    • Table Industry Structure
  • Industry Performance
    • Table Federal funding for Medicare and Medicaid
    • Table Industry revenue
    • Table Life Cycle Stage
  • Products & Markets
    • Table KEY BUYING INDUSTRIES
    • Table KEY SELLING INDUSTRIES
    • Table Products and services segmentation (2019)
    • Table Major market segmentation (2019)
    • Table Industry trade balance
    • Table Exports To...
    • Table Business Locations 2019
    • Table Distribution of establishments vs. population
  • Competitive Landscape
    • Table Sector vs. Industry Costs
    • Table Barriers to Entry checklist
    • Table Trade Globalization
  • Major Companies
    • Table Major Players
    • Table Sandoz Ltd. (US industry-specific segment) - financial performance*
    • Table Mylan Inc. (US industry-specific segment) - financial performance*
    • Table Teva Pharmaceutical Industries Ltd. (US industry-specific segment) - financial performance*
  • Operating Conditions
    • Table Capital Intensity
    • Table Tools of the Trade: Growth Strategies for Success
    • Table Volatility vs. growth
  • Key Statistics
    • Table Industry Data
    • Table Annual Change
    • Table Key Ratios
    • Table Industry Financial Ratios
  • Jargon & Glossary

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook